Self-reactive antibodies (natural autoantibodies) in healthy individuals

Journal of Immunological Methods

Volumn 216, Issue 1-2, 1998, Pages 117-137

  Lacroix Desmazes, Sébastien ^a   Kaveri, Srini V ^a   Mouthon, Luc ^a   Ayouba, Ahidjo ^a   Malanchère, Evelyne ^a   Coutinho, Antonio ^a   Kazatchkine, Michel D ^a  

^a INSERM   (France)

Author keywords

Autoreactivity; Immunoglobulins; Natural autoantibodies; Repertoires

Indexed keywords

AUTOANTIBODY;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; AUTOIMMUNITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW;

EID: 0032124204     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00074-X     Document Type: Article

References (200)

1. Adib-Conquy M., Avrameas S., Terninck T. Monoclonal IgM and IgG autoantibodies obtained after polyclonal activation, show reactivities similar to those of polyclonal natural autoantibodies. Molec. Immunol. 30:1993;119.
2. Adib M., Ragimbeau J., Avrameas S., Ternynck T. IgG autoantibody activity in normal mouse serum is controlled by IgM. J. Immunol. 145:1990;3807.
3. Algiman M., Dietrich G., Nydegger U., Boieldieu D., Sultan Y., Kazatchkine M.D. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3795.
4. Alt F., Blackwell T., Yancopoulos G. Development of the primary antibody repertoire. Science. 238:1987;1079.
5. Andersson J.P., Andersson U.G. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology. 71:1990;372.
6. Andersson A., Forsgren S., Soderstrom A., Holmberg D. Monoclonal natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. J. Autoimmun. 4:1991;733.
7. Andris, J.S., Capra, J.D., 1996. Variable region gene utilization in human antibodies to exogeneous antigens. In: Zanetti, M., Capra, J.D. (Eds.), The Antibodies. Harwood Academic Publishers, Amsterdam, p. 1.
8. +) B cells: a major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J. Immunol. 136:1986;505.
9. + cells and myasthenia gravis. Autoimmunity. 20:1995;129.
10. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol. Today. 12:1991;154.
11. Avrameas S., Ternynck T. Natural autoantibodies: the other side of the immune system. Res. Immunol. 146:1995;235.
12. Avrameas S., Guilbert B., Dighiero G. Natural antibodies against tubulin, actin, myoglobin, thyroglobulin, fetuin, albumin and transferrin are present in normal human sera and monoclonal immunoglobulins from multiple myeloma and Waldenström's macroglobulinemia may express similar antibody specificities. Ann. Inst. Pasteur Immunol. 132C:1981;231.
13. Avrameas S., Dighiero G., Lymberi P., Guilbert B. Studies on natural antibodies and autoantibodies. Ann. Inst. Pasteur Immunol. 134D:1983;103.
14. Ayouba A., Peltre G., Coutinho A. Quantitative analysis of multiple V region interactions among normal human IgG. Eur. J. Immunol. 26:1996;710.
15. Ayouba A., Ferreira C., Coutinho A. Distinguishable patterns of connectivity in serum immunoglobulins from SLE patients and healthy individuals. Scand. J. Immunol. 45:1997;408.
16. Baccala R., Vo Quang T., Gilbert M., Ternynck T., Avrameas S. Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes. Proc. Natl. Acad. Sci. U.S.A. 86:1989;4624.
17. Bakimer R., Fishman P., Blank M., Sredni B., Djaldetti M., Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J. Clin. Invest. 89:1992;1558.
18. Basta M., Langlois P.F., Marques M., Frank M.M., Fries L.F. High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood. 74:1989;326.
19. Basta M., Kirshbom P., Frank M.M., Fries L.F. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model. J. Clin. Invest. 84:1989;1974.
20. Bendtzen K., Svenson M., Jonsson V., Hippe E. Autoantibodies to cytokines - friends or foes? Immunol. Today. 11:1990;167.
21. Berman J.E., Nickerson K.G., Pollock R.R.et al. VH gene usage in humans: biased usage of the VH6 gene in immature B lymphoid cells. Eur. J. Immunol. 21:1991;1311.
22. Besredka M. Les antihémolysines naturelles. Ann. Inst. Pasteur. 15:1901;758.
23. Bikah G., Carey J., Ciallella J.R., Tarakhovsky A., Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science. 274:1996;1906.
24. Bouanani M., Piechaczyk M., Pau B., Bastide M. Significance of the recognition of certain antigenic regions on the thyroglobulin molecule by natural autoantibodies from healthy subjects. J. Immunol. 143:1989;1129.
25. Bouanani M., Bataille R., Piechaczyk M., Salhi S.L., Pau B., Bastide M. Respective epitopic specificity patterns of anti-human thyroglobulin autoantibodies in patients with Sjrögren's syndrome and patients with Hashimoto's thyroiditis. Arthritis Rheum. 34:1991;1585.
26. Boyden S. Natural antibodies and the immune response. Adv. Immunol. 5:1965;1.
27. Bresler H.S., Burek L.C., Hoffman W.H., Rose N.R. Autoantigenic determinants on human thyroglobulin: determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to auto-antibodies from healthy subjects. Clin. Immunol. Immunopathol. 54:1990;76.
28. + B cells from patients with rheumatoid arthritis. J. Exp. Med. 168:1988;1979.
29. Burnet, M., 1959. The Clonal Selection Theory of Acquired Immunity. Vanderbilt University Press, Nashville.
30. Cahalon L., Korem S., Gonen B., Puri J., Smorodinsky N.I., Witz I.P. Autoantibody-mediated regulation of tumor growth. Ann. N.Y. Acad. Sci. 651:1992;393.
31. + B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today. 10:1989;364.
32. + B lymphocytes. Ann. Rev. Immunol. 7:1989;513.
33. Chen P.P., Liu M.D., Glass C.A., Sinha S., Kipps T.J., Carson D.A. Characterization of two Ig VH genes which are homologous to human rheumatoid factors. Arthritis Rheum. 32:1989;72.
34. Chen C., Stenzel-Poore M.P., Rittenberg M.B. Natural auto- and polyreactive antibodies differing from antigen-induced antibodies in the H chain CDR3. J. Immunol. 147:1991;2359.
35. Chen J.J., Kaveri S., Kohler H. Cryptic T cell epitopes in polymorphic immunoglobulin regions: evidence for positive repertoire selection during fetal development. Eur. J. Immunol. 22:1992;3077.
36. Chen Z.J., Wheeler J., Notkins A.L. Antigen-binding B cells and polyreactive antibodies. Eur. J. Immunol. 25(2):1995;579.
37. Chow D., Bennet R. Low natural antibody and low in vivo tumor resistance, in xid-bearing B-cell deficient mice. J. Immunol. 142:1989;3702.
38. Cohen I.R., Cooke A. Natural autoantibodies might prevent autoimmune disease. Immunol. Today. 7:1986;363.
39. Coutinho A. Beyond clonal selection and network. Immunol. Rev. 110:1989;63.
40. Coutinho, A., Kazatchkine, M.D., 1994. Autoimmunity. Physiology and Disease. John Wiley, New York.
41. Coutinho A., Kazatchkine M.D., Avrameas S. Natural autoantibodies. Curr. Opin. Immunol. 7:1995;812.
42. Crouzier R., Martin T., Pasquali J.L. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J. Immunol. 154:1995;4526.
43. Cuisinier A.-M., Guigou V., Boubli L., Fougereau M., Tonnelle C. Preferential expression of Vh5 and Vh6 immunoglobulin genes in early human B-cell ontogeny. Scand. J. Immunol. 30:1989;493.
44. Dalakas M.C. Intravenous immune globulin therapy for neurologic diseases. Ann. Intern. Med. 126:1997;721.
45. Diaw L., Magnac C., Pritsch O., Buckle M., Alzari P.M., Dighiero G. Structural and affinity studies of IgM polyreactive natural antibodies. J. Immunol. 158:1997;968.
46. Dietrich G., Piechaczyk M., Pau B., Kazatchkine M.D. Evidence for a restricted idiotypic and epitopic specificity of anti-thyroglobulin autoantibodies in patients with autoimmune thyroiditis. Eur. J. Immunol. 21:1991;811.
47. Dietrich G., Algiman M., Sultan Y., Nydegger U.E., Kazatchkine M.D. Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg). Blood. 79:1992;2946.
48. Dietrich G., Kaveri S.V., Kazatchkine M.D. A V region-connected autoreactive subfraction of normal human serum immunoglobulin G. Eur. J. Immunol. 22:1992;1701.
49. Dietrich G., Varela F., Hurez V., Bouanani M., Kazatchkine M.D. Selection of the expressed B cell repertoire by infusion of normal immunoglobulin G in a patient with autoimmune thyroiditis. Eur. J. Immunol. 23:1993;2945.
50. Dighiero G., Lymberi P., Mazie J.-C., Rouyre S., Butler-Browne G.S., Avrameas S. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J. Immunol. 131:1983;2267.
51. Dighiero G., Poncet P., Rouyre S., Mazie J. Newborn Xid mice carry the genetic information for the production of natural autoantibodies against DNA, cytoskeletal proteins, and TNP. J. Immunol. 136(11):1986;4000.
52. Dinarello C.A. Is there a role for Interleukin-1 blokade in Intravenous Immunoglobulin therapy. Immunol. Rev. 139:1994;173.
53. Dinarello C., Thompson R.C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today. 12:1991;404.
54. Durandy A., Thuillier L., Forveille M., Fischer A. Phenotypic and functional characteristics of human newborns' B lymphocytes. J. Immunol. 144:1990;60.
55. Durandy A., Schiff C., Bonnefoy J.Y.et al. Induction by anti-CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked IgM syndrome. Eur. J. Immunol. 23:1993;2294.
56. Dwyer D.S., Bradley R.J., Urquhart C.K., Kearney J.F. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature. 301:1983;611.
57. Elson C.J., Williams N.A. Autoreactive T cells repertoire. Immunol. Today. 16:1995;71.
58. Elson C.J., Naysmith J.D., Taylor R.B. B-cell tolerance and autoimmunity. Int. Rev. Exp. Pathol. 19:1979;137.
59. Filion M.C., Bradley A.J., Devine D.V., Décary F., Chartrand P. Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. Eur. J. Immunol. 25:1995;3123.
60. Francoeur A.M. Antibody fingerprinting: a novel method for identifying individual people and animals. Biotechnology. 6:1988;822.
61. Freitas A.A., Viale A.C., Sundblad A., Heusser C., Coutinho A. Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5640.
62. Galili U., Clark M.R., Shohet S.B. Excessive binding of natural anti-alpha-galactosyl immunoglobulin G to sickle erythrocytes may contribute to extra-vascular cell destruction. J. Clin. Invest. 77:1986;27.
63. Galili U., Basbaum C.B., Shohet S.B., Buehler J., Macher B.A. Identification of erythrocyte Gala1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J. Biol. Chem. 262:1987;4683.
64. Gilles J.G., Saint-Remy J.M. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. J. Clin. Invest. 94:1994;1496.
65. Gordon J., Rosenthal M. Failure to detect age-related increase of non-pathological autoantibodies. Lancet. i:1984;231.
66. Grabar P. Hypothesis. Autoantibodies and immunological theories: an analytical review. Clin. Immunol. Immunopathol. 4:1975;453.
67. Greenberg A.H., Chow D.A., Wolosin L.B. Natural antibodies: origin, genetics, specificity and role in host resistance to tumors. Clin. Immunol. Allergy. 3:1983;389.
68. Guigou V., Guilbert B., Moinier D.et al. Ig repertoire of human polyspecific antibodies and B-cell ontogeny. J. Immunol. 146:1991;1368.
69. Guilbert B., Dighiero G., Avrameas S. Naturally occuring antibodies against nine common antigens in normal human sera. I. Detection, isolation, and characterization. J. Immunol. 128:1982;2779.
70. Hahn B.H. Characteristics of pathogenic subpopulations of antibodies to DNA. Arthritis Rheum. 25:1981;747.
71. Hahn-Zoric B., Carlsson J., Björkander A.D., Osterhausl M.E., Mellander L., Hanson L.A. Presence of non-maternal antibodies in newborns of mothers with antibody deficiencies. Pediatric. Res. 32:1992;150.
72. Hanson, L.A., Telemo, E., 1997. Immunobiology and epidemiology of breast feeding in relation to prevention of inffections from a global perspective. In: (Eds.), Mucosal Immunol. Academic Press, p.
73. Hardy R.R., Hayakawa K., Shimizu M., Yamasaki K., Kishimoto T. Rheumatoid factor secretion from human Leu-1+ B cells. Science. 236:1987;81.
74. Hay F.C., Nineham L.J., Torrigiani G., Roitt I.M. 'Hidden' IgG antiglobulins in normal human serum. Clin. Exp. Immunol. 25:1976;185.
75. Hintner H., Romani N., Stanzl U., Grubauer G., Fritsch P., Lawley T.J. Phagocytosis of keratin filament aggregates following opsonization with IG anti-keratin filament autoantibodies. J. Invest. Dermatol. 88:1987;176.
76. Holmberg D., Forsgren S., Ivars F., Coutinho A. Reactions amongst IgM antibodies derived from normal, neonatal mice. Eur. J. Immunol. 14:1984;435.
77. Holmberg D., Wennerström G., Andrade L., Coutinho A. The high idiotypic connectivity of 'natural' newborn antibodies is not found in adult mitogen-reactive B cell repertoires. Eur. J. Immunol. 16:1986;82.
78. Holmberg D., Freitas A.A., Portnoi D., Jacquemart F., Avrameas S., Coutinho A. Antibody repertoires of normal BALB/c mice: B lymphocyte populations defined by state of activation. Immunol. Rev. 93:1986;147.
79. Huetz F., Larsson-Sciard E.L., Pereira P., Portnoï D., Coutinho A. T cell dependence of the natural autoreactive B cell activation in the spleen of normal mice. Eur. J. Immunol. 18:1988;1615.
80. Hurez V., Dietrich G., Kaveri S.V., Kazatchkine M.D. Polyreactivity is a property of natural and disease-associated human autoantibodies. Scand. J. Immunol. 38:1993;190.
81. Hurez V., Kaveri S.V., Kazatchkine M.D. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur. J. Immunol. 23:1993;783.
82. Hurez V., Kaveri S.V., Mouhoub A., Dietrich G., Mani J.C., Klatzmann D., Kazatchkine M.D. Anti-CD4 activity of normal human immunoglobulins G for therapeutic use (Intravenous immunoglobulin IVIg). Ther. Immunol. 1:1994;269.
83. Ichiyoshi Y., Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J. Exp. Med. 180:1994;885.
84. Ichiyoshi Y., Zhou M., Casali P. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific 'germ-line' natural antibody template. Analysis by V gene segment reassortment and site-directed mutagenesis. J. Immunol. 154:1995;226.
85. Imbach P., Barandun S., d'Apuzzo V.et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. i:1981;1228.
86. Isenberg D.A., Shoenfeld Y., Madaio M.P.et al. Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet. i:1984;417.
87. Jayne D.R.W., Esnault V.L.M., Lockwood C.M. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J. Autoimmun. 6:1993;207.
88. Jeong H.D., Teale J.M. Comparison of the fetal and adult functional repertoires by analysis of VH family expression. J. Exp. Med. 168:1988;589.
89. Jeong H.D., Teale J.M. VH gene repertoire of resting B cells. Preferential use of D-proximal families early in development may be due to distinct B cell subsets. J. Immunol. 143:1989;2752.
90. Jerne N.K. Towards a network theory of the immune system. Ann. Inst. Pasteur Immunol. 125C:1974;373.
91. Jerne N.K. Idiotypic networks and other preconceived ideas. Immunol. Rev. 79:1984;5.
92. Jerne N.K. The generative grammar of immune system. EMBO J. 4:1985;847.
93. Kanost D., McCluskey. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical. Eur. J. Immunol. 24:1994;1186.
94. Kasaian M.T., Ikematsu H., Casali P. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J. Immunol. 148:1992;2690.
95. Kaveri S.V., Kang C.Y., Kohler H. Natural mouse and human antibodies bind to a peptide derived from a germline variable heavy chain: evidence for evolutionary conserved self-binding locus. J. Immunol. 145:1990;4207.
96. Kaveri S., Vassilev T., Hurez V.et al. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use (IVIg). J. Clin. Invest. 97:1996;865.
97. Kay M.M.B., Goodman S., Whitfield C., Wong P., Zaki L., Rudoloff V. The senescent cell antigen is immunologically related to band 3. Proc. Natl. Acad. Sci. U.S.A. 80:1983;1631.
98. Kazatchkine, M.D., Kaveri, S.V. (Eds.), 1997. Therapeutic Immunomodulation with Normal Polyspecific Immunoglobulin G (Intravenous Immunoglobulin, IVIg). Harwood Academic Publishers, Langhorne.
99. Kazatchkine M.D., Dietrich G., Hurez V.et al. V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (IVIg). Immunol. Rev. 139:1994;79.
100. Kearney J., Vakil M. Idiotype-directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire. Immunol. Rev. 94:1986;39.
101. + T cells in Graves disease patients and healthy controls. J. Autoimmun. 8:1995;685.
102. Kipps T.J. The CD5 B Cell. Adv. Immunol. 47:1989;117.
103. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 350:1991;423.
104. - human cord blood B lymphocytes. Immunology. 85(2):1995;236.
105. Kohler H., Kieber-Emmons T., Srinivasan S.et al. Revised immune network concepts. Clin. Immunol. Immunopathol. 52:1988;104.
106. Lacroix-Desmazes S., Mouthon L., Coutinho A., Kazatchkine M.D. Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur. J. Immunol. 25:1995;2598.
107. Lacroix-Desmazes, S., Mouthon, L., Pashov, A. et al. Analysis of antibody reactivities toward self antigens of IgM of patients with Waldenström's Macroglobulinemia. Intern. Immunol., in press.
108. Landsteiner, K., 1945. The nature and specificity of antibodies. In: (Eds.), The Specificity of Serological Reactions. Harvard Univesity Press, Cambridge, MA, p. 127.
109. Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis. Adv. Immunol. 42:1988;233.
110. Logtenberg T., Young F.M., Van Es J.H., Gmelig-Meyling F.H.J., Alt F.W. Autoantibodies encoded by the most Jh-proximal human immunoglobulin heavy chain variable region gene. J. Exp. Med. 170:1989;1347.
111. Lundkvist I., Coutinho A., Varela F., Holmberg D. Evidence for a functional idiotypic network among natural antibodies in normal mice. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5074.
112. Lutz H., Wipf G. Naturally occuring autoantibodies to skeletal proteins from human red blood cells. J. Immunol. 128:1982;1695.
113. Lutz H., Bussolino F., Flepp R.et al. Naturally occuring anti-band 3 antibodies and complement together mediate phagocytosis of oxidatively stressed human eryhtrocytes. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7368.
114. Lutz H.U., Stammler P., Jelezarova E., Nater M., Spath P.J. High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes. Blood. 88:1996;184.
115. Lymberi P., Blancher A., Calvas P., Avrameas S. Natural autoantibodies in nude and normal outbred (Swiss) and inbred (BALB/c) mice. J. Autoimmun. 2(3):1989;283.
116. Lymberi P., Dighiero G., Ternynck T., Avrameas S. A high incidence of cross-reactive idiotypes among murine natural autoantibodies. Eur. J. Immunol. 15:1985;702.
117. Maire M.A., Mittey M., Lambert P.H. The presence of cryoprecipitable immunoglobulins in normal human sera may reflect specific molecular interactions. Autoimmunity. 2:1989;155.
118. Malanchere E., Huetz F., Coutinho A. Maternal IgG stimulates B lineage cell development in the progeny. Eur. J. Immunol. 27:1997;788.
119. - B-cell chronic lymphocytic leukemia. Blood. 86(10):1995;3883.
120. Malynn B.A., Yancopoulos G.D., Barth J.E., Bona C.A., Alt F.W. Biaised expression of JH-proximal VH genes occur in newly generated repertoire of neonatal and adult mice. J. Exp. Med. 171:1990;843.
121. Manoussakis M.N., Tzioufas A.G., Silis M.P., Pange P.J.E., Goudevenos J., Moutsopoulos H.M. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin. Exp. Immunol. 69:1987;557.
122. Marchalonis J.J., Kaymaz H., Dedeoglu F., Schlutter S.F., Yocum D.E., Edmundson A.B. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor ß chain. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3325.
123. Marchalonis J.J., Kaymaz H., Schluter S.F., Yocum D.E. Naturally occurring human autoantibodies to defined T-cell receptor and light chain peptides. Adv. Exp. Med. Biol. 347:1994;135.
124. Marcos M.A., Sundblad A., Malenchere E., Coutinho A. Peritoneal B cells regulate the numbers of allotype-matched pre-B and B cells in bone marrow. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9944.
125. Mariotti S., Sansoni P., Barbesino G.et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. 339:1992;1506.
126. Martin R., Jaraquemada D., Flerlage M.et al. Fine specificity and restriction of myelin basic protein specific cytotoxic T cell lines from multiple sclerosis patients and healthy controls. J. Immunol. 145:1990;540.
127. Martin T., Crouzier R., Weber J., Kipps T., Pasquali J. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determinig region of the antibody heavy chain. J. Immunol. 152:1994;5988.
128. Mendlovic S., Brocke S., Shoenfeld Y.et al. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. U.S.A. 85:1988;2260.
129. Michael J.G. Natural antibodies. Curr. Top Microbiol. Immunol. 48:1969;43.
130. Michel C., Gonzalez R., Bonjour E., Avrameas S. A concurrent increasing of natural antibodies and enhancement of resistance of furonculosis in rainbow trout. Ann. Rech. Vet. 21:1990;211.
131. Miletic V.D., Hester C.G., Frank M.M. Regulation of complement activity by immunoglobulin. J. Immunol. 156:1996;749.
132. Miller D.J., Rodriguez M. A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J. Immunol. 154:1995;2460.
133. + T cells of myasthenia gravis patients and healthy subjects. J. Clin. Invest. 93:1994;1020.
134. Moulias R., Proust J., Wang A.et al. Age-related increase in autoantibodies. Lancet. i:1984;1128.
135. Mouthon L., Haury M., Lacroix-Desmazes S., Barreau C., Coutinho A., Kazatchkine M.D. Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J. Immunol. 154:1995;5769.
136. Mouthon L., Nobrega A., Nicolas N.et al. Invariance and restriction towards a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3839.
137. Mouthon L., Lacroix-Desmazes S., Nobrega A., Barreau C., Coutinho A., Kazatchkine M.D. The self-reactive antibody repertoire of normal human serum IgM is acquired in early childhood and remains stable throughout life. Scand. J. Immunol. 44:1996;243.
138. Muryoi T., Sasaki T., Harata N., Takai O., Tamate E., Yoshinaga K. Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans. Clin. Exp. Immunol. 71:1988;67.
139. Naito N., Saito K., Hosoya T.et al. Anti-thyroglobulin autoantibodies in sera from patients with chronic thyroiditis and from healthy subjects: differences in cross-reactivity with thyroid peroxidase. Clin. Exp. Immunol. 80:1990;4.
140. + B cells are polyreactive. J. Immunol. 140:1986;4180.
141. Nakamura M., Burastero S.E., Ueki Y., Larrick J.W., Notkins A.L., Casali P. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus: frequency of B cell producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J. Immunol. 141:1988;4165.
142. Navin T., Krug E., Pearson R. Effect of immunoglobulin M from normal human serum on Leishmania donovani promastigote agglutination, complement-mediated killing and phagocytosis by human monocytes. Infect. Immun. 57:1989;1343.
143. Nickerson K.G., Berman J., Glickman E., Chess L., Alt F.W. Early human IgH gene assembly in Epstein-Barr virus transformed fetal B cells studies. Preferential utilization of the most JH-proximal D segment (DQ52) and two unusual VH-related rearrangements. J. Exp. Med. 169:1989;1391.
144. Nicoletti A., Kaveri S.V., Caligiuri G., Bariety J., Hansson G., 1998. Immunoglobulin treatment reduces atherosclerosis in apoE knockout mice. J. Clin. Invest., in press.
145. Nobrega A., Haury M., Grandien A., Malanchère E., Sunblad A., Coutinho A. Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological 'homunculus' of antibodies in normal serum. Eur. J. Immunol. 23:1993;2851.
146. Nobrega A., Haury M., Gueret R., Coutinho A., Weksler M. The age-associated increase in autoreactive immunoglobulins reflects a quantitative increase in specificities detectable at lower concentrations in young mice. Scand. J. Immunol. 44(5):1996;437.
147. Nobrega, A., Malanchère, E., Hecker, L., Haury, M., Grandien, A., Coutinho, a.A., 1997. Diversity of antibody repertoire. I. Clonal frequencies of reactivities and patterns of complex clonal mixtures on immunoblots of natural antigens. Eur. J. Immunol.
148. Pashov, A., Kaveri, S., Kazatchkine, M.D., Bellon, B., 1996. Suppression of experimental autoimmune encephalomyelitis by intravenous immunoglobulin. In: Kazatchkine, M.D., Morell, A. (Eds.), Intravenous Immunoglobulin and Therapy. Parthenon, New York, p. 317.
149. Pashov A., Dubey, C., Kaveri, S.V., Lectard, B., Huang, Y., Kazatchkine, M.D., Bellon, B., 1998. Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein. Eur. J. Immunol, in press.
150. Pechaczyk M., Bouanani M., Salhi S.L., Baldet L., Bastide M., Pau B., Bastide J.M. Antigenic domains on the human thyroglobulin molecule recognized by autoantibodies in patient's sera and by natural autoantibodies isolated from sera of healthy subjects. Clin. Immunol. Immunopathol. 45:1987;114.
151. Pereira P., Forni L., Larsson E.L., Cooper M.D., Heusser C., Coutinho A. Autonomous activation of B and T cells in antigen-free mice. Eur. J. Immunol. 16:1986;685.
152. Pfueller S.L., Logan D., Tran T.T., Bilston R.A. Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets. Clin. Exp. Immunol. 79:1990;367.
153. Poutsiaka D.D., Clark B.D., Vannier E., Dinarello C.A. Production of IL-receptor antagonist and IL-1ß by peripheral blood mononuclear cells is differentially regulated. Blood. 78:1991;1275.
154. Prabhakar B.S., Saegusa J., Onodera T., Notkins A.L. Lymphocytes capable of making monoclonal antibodies that react with multiple organs are a common feature of the normal B cell repertoire. J. Immunol. 133:1984;2815.
155. Raaphorst F.M., Timmers E., Kenter M.J.H., Van Tol M.J.D., Vossen J.M., Schuurman R.K.B. Restricted utilization of germ-line Vh3 genes and short diverse third complementarity-determining regions (CDR 3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements. Eur. J. Immunol. 22:1992;247.
156. Reth M.G., Jackson S., Alt F.W. VhDJH formation and DJH replacement during pre-B cell differentiation: non-random usage of gene segments. EMBO J. 5:1986;2131.
157. Ronda N., Haury M., Nobrega A., Kaveri S.V., Coutinho A., Kazatchkine M.D. Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int. Immunol. 6:1994;1651.
158. Rossi F., Dietrich G., Kazatchkine M.D. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses. Immunol. Rev. 110:1989;135.
159. Rossi F., Kazatchkine M.D. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J. Immunol. 143:1989;4104.
160. Rossi F., Guilbert B., Tonnelle C.et al. Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies. Eur. J. Immunol. 20:1990;2089.
161. Rossi F., Bellon B., Vial M.C., Druet P., Kazatchkine M.D. Beneficial effect of human therapeutic intravenous immunoglobulins (IVIg) in mercuric-chloride-induced autoimmune disease of Brown-Norway rats. Clin. Exp. Immunol. 84:1991;129.
162. Rossi F., Jayne D.R.W., Lockwood C.M., Kazatchkine M.D. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin. Exp. Immunol. 83:1991;298.
163. Roux K.H., Tankersley D.L. A view of the human idiotypic repertoire: electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG. J. Immunol. 144:1990;1387.
164. Rudensky A.Y., Mazel S.M., Yurin V.L. Presentation of endogenous immunoglobulin determinants to immunoglobulin-recognizing T cell clones by the thymic cells. Eur. J. Immunol. 20:1990;2235.
165. Ruiz-Arguelles A. Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an anti-idiotypic antibody directed to an interspecies cross-reactive idiotype expressed on anti-fibrinogen antibodies. J. Clin. Invest. 82:1988;958.
166. Ruiz de Souza V., Carreno M.P., Kaveri S.V.et al. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur. J. Immunol. 25:1995;1267.
167. Sabbaga J., Pankewycz O.G., Lufft V., Schwartz R.S., Madaio M.P. Cross-reactivity distinguishes serum and nephritigenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J. Autoimmun. 3:1990;215.
168. Saenko V.A., Kabakov A.E., Poverenny A.M. Hidden high-avidity anti-DNA antibodies occur in normal human gammaglobulin preparations. Immunol. Lett. 34:1992;1.
169. Sanz I., Dang H., Takei M., Talal N., Capra J.D. Vh sequence of a human anti-Sm autoantibody: Evidence that autoantibodies can be unmutated copies of germline genes. J. Immunol. 142:1989;883.
170. Saoudi A., Hurez V., de Kozak Y.et al. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis. Int. Immunol. 5:1993;1559.
171. Schettino, E.W., Ichiyoshi, Y., Casali, P., 1996. Structure-function relation in natural and disease-associated human autoantibodies. In: Zanetti, M., Capra, J.D. (Eds.), The Antibodies. Harwood Academic Publishers, Amsterdam, p. 155.
172. Schroeder H.W., Wang J.Y. Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6146.
173. Schroeder H.W., Hillson J.L., Perlmutter P.M. Early restriction of the human antibody repertoire. Science. 238:1987;791.
174. + B cell lines. Eur. J. Immunol. 21:1991;1115.
175. Spalter, S.H., Kaveri, S., Mani, J.C., Kazatchkine, M.D., 1997. Natural antibodies of the IgG and IgM isotypes reactive with self ABO blood group antigens are present in normal human serum, submitted.
176. Stewart J. Immunoglobulins did not arise in evolution to fight infection. Immunol. Today. 13(10):1992;396.
177. Sultan Y., Kazatchkine M.D., Maisonneuve P., Nydegger U.E. Anti-idiotypic suppression of autoantibodies to Factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. ii:1984;765.
178. Sultan Y., Rossi F., Kazatchkine M.D. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. Proc. Natl. Acad. Sci. U.S.A. 84:1987;828.
179. Sundblad A., Marcos M., Huetz F.et al. Normal serum immunoglobulins influence the number of bone marrow pre-B and B cells. Eur. J. Immunol. 21:1991;1155.
180. Sundblad A., Marcos M., Malenchere E.et al. Observations on the mode of action of normal immunoglobulin at high-doses. Immunol. Rev. 139:1994;125.
181. Svenson M., Hansen M.B., Bendtzen K. Distribution and characterization of autoantibodies to interleukin 1 α in normal human sera. Scand. J. Immunol. 32:1990;695.
182. Talor E., Rose N.R. Hypothesis: the aging paradox and autoimmune disease. Autoimmunity. 8:1991;245.
183. Tankersley D.L., Preston M.S., Finlayson J.S. Immunoglobulin G dimer: an idiotype-anti-idiotype complex. Mol. Immunol. 25:1988;41.
184. Ternynck T., Avrameas S. Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities. Immunol. Rev. 94:1986;99.
185. Thornton B.P., Vetvicka V., Ross G.D. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1994;1727.
186. Tighe H., Chen P.P., Tucker R.et al. Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J. Exp. Med. 177:1993;109.
187. Tomer Y., Shoenfeld Y. Aging and autoantibodies. Autoimmunity. 1:1988;141.
188. van Doorn P.A., Rossi F., Brand A., van Lint M., Vermeulen M., Kazatchkine M.D. On the mechanism of high dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 29:1990;57.
189. Varela F., Coutinho A. Second generation immune networks. Immunol. Today. 12:1991;159.
190. Vassilev T., Gelin C., Kaveri S.V., Zilber M.T., Boumsell L., Kazatchkine M.D. Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins IVIg). Clin. Exp. Immunol. 92:1993;369.
191. Vassilev T., Bineva I., Dietrich G., Kaveri S.V., Kazatchkine M.D. Variable region-connected, dimeric fraction of intravenous immunoglobulin enriched in natural autoantibodies. J. Autoimmun. 8:1995;405.
192. Vassilev, T., Kazatchkine, M.D., Mani, J.C., Lecroubier, C., Schriever, F., Kaveri, S.V., 1997. Antibodies to to the RGD (Arg-Gly-Asp) Peptide, Capable of Inhibiting Cellular Adhesion Interactions, Are Present in Normal Immunoglobulin for Therapeutic Use (Intravenous immunoglobulin, IVIg), in preparation.
193. Weir D.M., Elson C.J. Antitissue antibodies and immunological tolerance to self. Arthritis Rheum. 12:1969;254.
194. Wilson, G.S., Miles, A.A., 1964. The natural antibodies: their nature, origin and behaviour. In: Wilson, T.A. (Ed.), Principle of Bacteriology and Immunity. Edward Arnold, London, p. 1315.
195. Witz I., Yaakubowicz M., Gelernter I.et al. Studies on the level of natural antibodies reactive with various tumor cells during urethane carcinogenesis in BALB/c mice. Immunobiology. 166:1984;131.
196. Xu, C., Poirier, B., Lavaud, S. et al., 1997. Normal polyspecific human immunoglobulins IVIg modulate endothelial cell function in vitro, in preparation.
197. Yadin O., Sarov B., Naggan L., Slor H., Shoenfeld Y. Natural autoantibodies in the serum of healthy women - a five year follow-up. Clin. Exp. Immunol. 75:1989;402.
198. - B cells of autoimmune NZB x NZW F1 mice. Clin. Exp. Immunol. 106(2):1996;253.
199. Youinou P.Y., Mackenzie L., Masson G.L.et al. CD5-Expressing B lymphocytes in the blood and salivery glands of patients with Primary Sjögren's syndrome. J. Autoimmun. 1:1988;185.
200. Zouali M., Eyquem A. Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillary levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient. Ann. Inst. Pasteur Immunol. 134C:1983;377.